EMA
safety_alert
· 2014-11-21
European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)
Summary
EMA recommends measures to reduce risk of heart problems with ivabradine (Corlentor/Procoralan) including restricting use and monitoring due to potential heart-…
Upgrade for the full analysis, importance score, and drug timeline.